Articles by Céline Bouchard, MD

Vasomotor symptoms and breast cancer: WHI continues to surprise us

Bouchard, Céline

Menopause. 26(6):571-572, June 2019.

PDF
Permissions

Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal women

Portman, David J.; Labrie, Fernand; Archer, David F.; More

Menopause. 22(12):1289-1295, December 2015.

Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone)

Archer, David F.; Labrie, Fernand; Bouchard, Céline; More

Menopause. 22(9):950-963, September 2015.

Coffee or caffeine intake and effects on menopausal symptoms: unsolved issue

Bouchard, Céline

Menopause. 22(2):129-130, February 2015.

PDF
Permissions

Prevention of falls, prevention of osteoporosis, or both: what is the best strategy for preventing fractures in older women?

Bouchard, Céline

Menopause. 20(10):995-996, October 2013.

PDF
Permissions

Selective estrogen receptor modulators and their effects on hot flashes: a dilemma

Bouchard, Céline

Menopause. 18(5):477-479, May 2011.

PDF
Permissions

Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration

Labrie, Fernand; Archer, David; Bouchard, Céline; More

Menopause. 16(5):897-906, September-October 2009.

Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy

Labrie, Fernand; Archer, David; Bouchard, Céline; More

Menopause. 16(5):907-922, September-October 2009.

Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women

Labrie, Fernand; Archer, David; Bouchard, Céline; More

Menopause. 16(5):923-931, September-October 2009.

Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally

Bachmann, Gloria; Bouchard, Céline; Hoppe, Diana; More

Menopause. 16(4):719-727, July-August 2009.

Herbal alternatives as substitutes for hormone therapy in urogenital atrophy: scientific evidence is needed

Bouchard, Céline

Menopause. 15(1):12-13, January 2008.

PDF
Permissions

Hot flashes: what are women's expectations from therapeutic options?

Bouchard, Céline

Menopause. 14(2):166-167, March-April 2007.

PDF
Permissions

Secondary Logo

Journal Logo

Articles by Céline Bouchard, MD

Vasomotor symptoms and breast cancer: WHI continues to surprise us

Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal women

Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone)

Coffee or caffeine intake and effects on menopausal symptoms: unsolved issue

Prevention of falls, prevention of osteoporosis, or both: what is the best strategy for preventing fractures in older women?

Selective estrogen receptor modulators and their effects on hot flashes: a dilemma

Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration

In Brief:

Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy

In Brief:

Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women

In Brief:

Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally

In Brief:

Herbal alternatives as substitutes for hormone therapy in urogenital atrophy: scientific evidence is needed

Hot flashes: what are women's expectations from therapeutic options?

More About This Author